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Stimulus Money and Health Care Research and Investment
On February 17, 2009 the American Recovery
and Reinvestment Act (ARRA) – or, as commonly
referred to in the media, the Stimulus Bill – was
signed into law. The legislation allocates $787
billion for federal stimulus spending in an attempt
to curb the current economic recession. Of the
total, $150 billion has been allocated to health
care (Figure 1). Health care represents the largest
proportion of dedicated funds as well as the
largest sector of the economy.1 Thus, recovery and
well-being of the economy is inexorably tied to
the condition of the healthcare industry. The $150
billion allotment is viewed as the jumping-off
point for the Obama administration’s healthcare
agenda, which seeks to increase access to services
while controlling cost. Because this will have both
immediate and long-term effects for everyone in
the nation, it is imperative for all to understand
the broad health policy implications.
Over half (58%) of the health care stimulus
funds – $87 billion– will be devoted to states
in the form of matching federal assistance for
Medicaid.2 The remainder of the health care
stimulus dollars are pegged for three broad
initiatives: comparative effectiveness research,
health information technology, and increased
funding ($10.4 billion) for the National Institutes
of Health (NIH).2,3 These three initiatives have the
potential to profoundly affect healthcare policy
and the future direction of the healthcare industry.
Specifically, the ARRA apportions $1.1 billion
for comparative effectiveness research, one of
the more controversial funding initiatives.2
Because comparative effectiveness is in its
nascent stage in the United States, many have
presupposed its implications and have a deeprooted misunderstanding of this form of science.
In its simplest form, comparative effectiveness
research can be boiled down to the comparison of
alternative treatments for a medical condition to
determine the best overall treatment strategy. 4
In practice, it is not this simple; there are many
methodological and policy challenges. Foremost,
researchers must determine the appropriate

Figure 1: Allocation of Health Care
Stimulus Funds ($150 Billion)

Comparative Effectiveness Research
Health Information Technology
Other
Medicaid and Other State Health Programs
National Institutes of Health

outcome measure for which to compare distinct
or contrasting interventions. Another important
component of comparative effectiveness research
is economic evaluations of interventions. However,
interventions which improve health outcomes
do not always save money and, in fact, can be
significantly more expensive than the current
standard of care. As such, policy makers are forced
to determine at what costs they are willing to fund
interventions which improve healthcare.
While there are clear methodological and
political challenges to conducting comparative

effectiveness research, it should not be discounted
nor touted as the savior of health reform. Rather,
when implemented as part of an overall evidencebased medicine agenda, comparative effectiveness
research has the potential to curb rampant health
care inflation and improve overall quality of care.
To oversee funding of comparative effectiveness
research and to help alleviate the fear of the
government using findings from this type of
research to directly dictate medical coverage,
the Federal Coordinating Council for Comparative
Effectiveness Research (FCC-CER) was established
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on March 19, 2009. Comprised of a 15-member
expert panel, the FCC-CER role is to submit reports
to Congress on the comparative effectiveness
research being conducted; it will not be able to
mandate coverage or set healthcare policy.1,4
The health care appropriation will also direct
$19.2 billion to healthcare technology and
infrastructure investments with the ultimate
goal of the implementation of an electronic
health record for every person in the United
States by 2014.2 To achieve this goal, the funds
will initially be used to provide incentives
to doctors and hospitals to adopt the use of
electronic health records.1
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The money will also be used to train workers in
the use of health information technology and
improve the security of electronic health records.
Finally, the legislation allocates an additional
$10.4 billion to NIH (approximately 1/3 of the
current NIH budget), which must be spent in
two years.2,3 Of the total, $2.2 billion is dedicated to
capital improvements of facilities, infrastructure
and equipment to improve healthcare
infrastructure and provide jobs as a way to
stimulate the economy. The remaining $8.2 billion
is intended for peer-reviewed research grants.2

policy, where costs are controlled and quality is
demanded. Innovation is imperative, and novel
ideas and approaches to solving the health care
crisis are welcomed from all disciplines. In order
to sustain lasting improvement, policy makers
must remember to continue to invest in the
nation’s healthcare system after the stimulus
funds expire. 
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This tidal wave of money devoted to health care
marks the beginning of a new era in health
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